Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Lubiprostone prevents NSAID-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators via EP4 Receptors
Shusaku Hayashi, Naoto Kurata, Aya Yamaguchi, Kikuko Amagase and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics April 8, 2014, jpet.114.213991; DOI: https://doi.org/10.1124/jpet.114.213991
Shusaku Hayashi
Kyoto Pharmaceutical University
Naoto Kurata
Kyoto Pharmaceutical University
Aya Yamaguchi
Kyoto Pharmaceutical University
Kikuko Amagase
Kyoto Pharmaceutical University
Koji Takeuchi
Kyoto Pharmaceutical University
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Lubiprostone prevents NSAID-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators via EP4 Receptors
Shusaku Hayashi, Naoto Kurata, Aya Yamaguchi, Kikuko Amagase and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics April 8, 2014, jpet.114.213991; DOI: https://doi.org/10.1124/jpet.114.213991
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Lubiprostone prevents NSAID-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators via EP4 Receptors
Shusaku Hayashi, Naoto Kurata, Aya Yamaguchi, Kikuko Amagase and Koji Takeuchi
Journal of Pharmacology and Experimental Therapeutics April 8, 2014, jpet.114.213991; DOI: https://doi.org/10.1124/jpet.114.213991
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement